New concepts for phase I trials: evaluating new drugs combined with radiation therapy (Q36304022)

13 August 2017

1 reference

title

New concepts for phase I trials: evaluating new drugs combined with radiation therapy (English)

1 reference

adaptive radiation therapy

13 August 2017

main subject

phase I clinical trial

0 references

0 references

2

Jean Charles Soria

0 references

Eric Deutsch

object named as

Eric Deutsch

series ordinal

1

0 references

author name string

Jean Charles Soria

series ordinal

2

1 reference

13 August 2017

Jean Pierre Armand

series ordinal

3

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

456-465

1 reference

Radiation oncology: a century of achievements.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Comparing different NTCP models that predict the incidence of radiation pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Development of Investigational Radiation Modifiers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Nontoxicity endpoints in phase I trial designs for targeted, non-cytotoxic agents

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: theory and practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0295

7 January 2021

Identifiers

DOI

10.1038/NCPONC0295

1 reference

13 August 2017

1 reference